Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In cross-sectional studies, elevated plasma homocysteine levels have been associated with poor cognition and dementia. Studies of newly diagnosed dementia are required in order to establish whether the elevated homocysteine levels precede the onset of dementia or result from dementia-related nutritional and vitamin deficiencies. METHODS: A total of 1092 subjects without dementia (667 women and 425 men; mean age, 76 years) from the Framingham Study constituted our study sample. We examined the relation of the plasma total homocysteine level measured at base line and that measured eight years earlier to the risk of newly diagnosed dementia on follow-up. We used multivariable proportional-hazards regression to adjust for age, sex, apolipoprotein E genotype, vascular risk factors other than homocysteine, and plasma levels of folate and vitamins B12 and B6. RESULTS: Over a median follow-up period of eight years, dementia developed in 111 subjects, including 83 given a diagnosis of Alzheimer's disease. The multivariable-adjusted relative risk of dementia was 1.4 (95 percent confidence interval, 1.1 to 1.9) for each increase of 1 SD in the log-transformed homocysteine value either at base line or eight years earlier. The relative risk of Alzheimer's disease was 1.8 (95 percent confidence interval, 1.3 to 2.5) per increase of 1 SD at base line and 1.6 (95 percent confidence interval, 1.2 to 2.1) per increase of 1 SD eight years before base line. With a plasma homocysteine level greater than 14 micromol per liter, the risk of Alzheimer's disease nearly doubled. CONCLUSIONS: An increased plasma homocysteine level is a strong, independent risk factor for the development of dementia and Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adjudication for Alzheimer’s phenotypes was done by a committee41, comprising at least two neurologists and a neuropsychologist.”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [41]
In the citing paper
“Dementia diagnoses were made according to DSM‐IV criteria, based on longitudinal cognitive assessments, caregiver interviews, medical records, neuroimaging, and autopsy data when available.”
From Blood PCSK9 Impacts Alzheimer's Disease Risk in an APOE Genotype‐Dependent Manner: A Prospective Cohort Study (2026) · cites this paper as [18]
In the citing paper
“Overall, of the 19 selected cohort studies linking Hcy to the various cognitive outcomes, 12(63.2%) found the relationship in the hypothesized direction in the entire population that was studied and for most outcomes of interest [206,215,217,219,222-224,228,231,233-235]”
From Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis (2014) · cites this paper as [206]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Homocysteine and Atherothrombosis
Welch, G. N., & Loscalzo, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804093381507 · Cited by 1,997
Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Selhub, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510220049033 · Cited by 1,972
Self-citationBrookmeyer, R., Gray, S., & Kawas, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,787
A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians
Stampfer, M. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490070059042 · Cited by 1,709
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
Aging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,440
Research works printed but not linked: 3
- Berg L, 1988, Psychopharmacol Bull, 24, 637
- Levin ML, 1953, Acta Unio Int Contr Cancrum, 9, 531
- 1996, Fed Regist, 61, 8781
Cited by
Items 401–500 of 1,022
Yang, L., Su, Y., Geng, Y., Zhang, Y., Ren, X., He, L., & Song, X. (2018) · ACS Sensors · doi:10.1021/acssensors.8b00685 · Cited by 126
Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?
Humpel, C. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2010.11.032 · Cited by 124
Discriminative Fluorescence Sensing of Biothiols in Vitro and in Living Cells
Miao, Q., Li, Q., Yuan, Q., Li, L., Hai, Z., Liu, S., & Liang, G. (2015) · Analytical Chemistry · doi:10.1021/ac504836a · Cited by 124
Xu, R., Huang, F., Wang, Y., Liu, Q., Lv, Y., & Zhang, Q. (2020) · Scientific Reports · doi:10.1038/s41598-020-74596-7 · Cited by 141
Chen, H., Liu, S., Ge, B., Zhou, D., Li, M., Li, W., Ma, F., Liu, Z., Ji, Y., & Huang, G. (2021) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2021.22 · Cited by 135
“Increased levels of Hcy are associated with a high risk of coronary stroke, heart diseases, and cognitive impairment, which commonly accompany AD and dementia (19, 20).”
Dangour, A. D., Whitehouse, P. J., Rafferty, K., Mitchell, S. A., Smith, L., Hawkesworth, S., & Vellas, B. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-090940 · Cited by 123
“Homocysteine Five cohort studies (Table 1) reported data on the relationship between levels of serum homocysteine and development of incident dementia and/or AD [26,28, 29,33,35].”
InfluentialVogel, T., Dali-Youcef, N., Kaltenbach, G., & Andrès, E. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02026.x · Cited by 125
Karakis, I., Pase, M. P., Beiser, A., Booth, S. L., Jacques, P. F., Rogers, G. T., DeCarli, C. S., Vasan, R. S., Wang, T. J., Himali, J. J., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150991 · Cited by 130
“Homocysteine levels were determined as previously described [15], and log transformed.”
Self-citationThe determination of homocysteine–thiolactone in human plasma
Chwatko, G., & Jakubowski, H. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.11.035 · Cited by 126
Homocysteine and holotranscobalamin and the risk of Alzheimer disease: A longitudinal study
Hooshmand, B., Solomon, A., Kåreholt, I., Leiviskä, J., Rusanen, M., Ahtiluoto, S., Winblad, B., Laatikainen, T., Soininen, H., & Kivipelto, M. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f88162 · Cited by 122
Present and future of folate biofortification of crop plants
Blancquaert, D., Steur, H. D., Gellynck, X., & Straeten, D. V. D. (2014) · Journal of Experimental Botany · doi:10.1093/jxb/ert483 · Cited by 129
“, 2012), Alzheimer disease (Seshadri et al., 2002), cardiovascular (Scott and Weir, 1996) and coronary diseases (Stanger, 2004), stroke (Endres et al.”
BackgroundA mitochondria-targeted turn-on fluorescent probe for the detection of glutathione in living cells
Zhang, J., Bao, X., Zhou, J., Peng, F., Ren, H., Dong, X., & Zhao, W. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.05.005 · Cited by 122
Khan, Z. G., & Patil, P. O. (2020) · Microchemical Journal · doi:10.1016/j.microc.2020.105011 · Cited by 128
Baydaş, G., Reiter, R. J., Akbulut, M., Tuzcu, M., & Tamer, S. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.05.048 · Cited by 124
Nutrient intake and psychological health in an elderly Chinese population
Woo, J., Lynn, H., Lau, W. Y., Leung, J., Lau, E., Wong, S. Y. S., & Kwok, T. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1603 · Cited by 122
“2005), B12, folate and plasma homocysteine levels (Selhub et al., 2000; Budge et al., 2002; Duthie et al., 2002; Reynolds, 2002; Seshadri et al., 2002; Elias et al., 2005; Tucker et al., 2005), fish/omega-3 fatty acids (Morris et al.”
BackgroundWang, X., Lv, J., Yao, X., Li, Y., Huang, F., Li, M., Yang, J., Ruan, X., & Tang, B. (2014) · Chemical Communications · doi:10.1039/c4cc06637e · Cited by 123
Associations between B Vitamins and Parkinson’s Disease
Shen, L. (2015) · Nutrients · doi:10.3390/nu7095333 · Cited by 120
“Hcy exhibits multiple neurotoxic effects involved in the pathogenesis of several neurodegenerative disorders, including dementia, Alzheimer’s disease and PD [6–8].”
Markun, S., Gravestock, I., Jäger, L., Rosemann, T. J., Pichierri, G., & Burgstaller, J. M. (2021) · Nutrients · doi:10.3390/nu13030923 · Cited by 153
Blasko, I., Jellinger, K. A., Kemmler, G., Krampla, W. W., Jungwirth, S., Wichart, I., Tragl, K. H., & Fischer, P. A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.09.002 · Cited by 130
Circulating Biomarkers of Cognitive Decline and Dementia
Solfrizzi, V., D'Introno, A., Colacicco, A. M., Capurso, C., Todarello, O., Pellicani, V., Capurso, S. A., Pietrarossa, G., Santamato, V., Capurso, A., et al. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.015 · Cited by 120
Serum homocysteine and dementia: Meta‐analysis of eight cohort studies including 8669 participants
Wald, D. S., Kasturiratne, A., & Simmonds, M. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.08.234 · Cited by 120
“However, the reports from such studies have been inconsistent; some concluded positive association [10,11], whereas others concluded no association [12,13], leaving the position uncertain.”
BackgroundResultDietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer's disease1
Morris, M. C., Evans, D. A., Schneider, J. A., Tangney, C. C., Bienias, J. L., & Aggarwal, N. T. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9410 · Cited by 120
Iron, neuroinflammation, and Alzheimer's disease
Ong, W.-Y., & Farooqui, A. A. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-8211 · Cited by 120
“Patients with homocysteinemia have been reported to have increased risk of AD [73,74].”
Successful Mental Health Aging: Results From a Longitudinal Study of Older Australian Men
Almeida, O. P., Norman, P. E., Hankey, G. J., Jamrozik, K. D., & Flicker, L. A. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000192486.20308.42 · Cited by 137
Mitochondrial failures in Alzheimer's disease
Zhu, X., Smith, M. A., Perry, G., & Aliev, G. (2004) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/153331750401900611 · Cited by 118
The central nervous system in animal models of hyperhomocysteinemia
Troen, A. M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.06.025 · Cited by 119
“, 2002) and Alzheimer’s disease (Joosten et al., 1997; McCaddon et al., 1998; Clarke et al., 1998; Seshadri et al., 2002).”
BackgroundNeuropathy as a potential complication of levodopa use in Parkinson's disease
Toth, C. C., Brown, M. S., Furtado, S., Suchowersky, O., & Zochodne, D. W. (2008) · Movement Disorders · doi:10.1002/mds.22137 · Cited by 135
“Sufficient evidence now exists for elevated homocysteine to be a risk factor for stroke, coronary artery disease, and dementia.(4,5) The relationship of vitamin B12 deficiency and elevated homocystine (Hcy) and elevated methylmalonic”
BackgroundMethylation and acetylation in nervous system development and neurodegenerative disorders
Mattson, M. P. (2003) · Ageing Research Reviews · doi:10.1016/s1568-1637(03)00013-8 · Cited by 131
González‐Domínguez, R., García, A., García‐Barrera, T., Barbas, C., & Gómez‐Ariza, J. L. (2014) · ELECTROPHORESIS · doi:10.1002/elps.201400196 · Cited by 119
Zhang, D., Ye, J., Mu, J.-S., & Cui, X. (2016) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988716673466 · Cited by 135
“Hyperhomocysteinemia is associated with an increased risk of cognitive impairment in elderly patients.(2,4,5) In fact, the risk of Alzheimer disease is doubled with a plasma homocysteine level greater than 14 mmol/L.”
BackgroundPoddar, R., & Paul, S. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06207.x · Cited by 119
“Hyperhomocysteinemia is also associated with neurological abnormalities such as mental retardation, age-associated dementia, Alzheimer’s disease, Parkinson’s disease, cerebral atrophy, and seizures (Watkins and Rosenblatt 1989; Van den Berg et al. 1995; Gottfries et al. 1998; Miller 1999; Seshadri et al. 2002).”
BackgroundSun, Y., Lu, C.-J., Chien, K., Chen, S.-T., & Chen, R.-C. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.10.012 · Cited by 130
Vitamin B12, cognition, and brain MRI measures: A cross-sectional examination
Tangney, C. C., Aggarwal, N. T., Li, H., Wilson, R. S., DeCarli, C., Evans, D. A., & Morris, M. C. (2011) · Neurology · doi:10.1212/wnl.0b013e3182315a33 · Cited by 119
Chwatko, G., Boers, G. H. J., Strauss, K. A., Shih, D. M., & Jakubowski, H. (2007) · The FASEB Journal · doi:10.1096/fj.06-7435com · Cited by 119
“generative diseases such as Alzheimer’s (3).”
Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies
Nielsen, H. M., Minthon, L., Londos, E., Blennow, K., Miranda, E., Perez, J., Crowther, D. C., Lomas, D. A., & Janciauskiene, S. M. (2007) · Neurology · doi:10.1212/01.wnl.0000271077.82508.a0 · Cited by 119
Li, X., Qian, S., He, Q., Yang, B., Li, J. X., & Hu, Y. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/c004344c · Cited by 126
Stopa, E. G., Tanis, K. Q., Miller, M. C., Nikonova, E. V., Podtelezhnikov, A. A., Finney, E. M., Stone, D. J., Camargo, L. M., Parker, L., Verma, A., et al. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0102-9 · Cited by 118
Shen, L., & Ji, H. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150140 · Cited by 133
Pacheco-Quinto, J., Rodriguez de Turco, E. B., DeRosa, S., Howard, A., Cruz-Sanchez, F., Sambamurti, K., Refolo, L., Petanceska, S., & Pappolla, M. A. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.005 · Cited by 118
“Keywords: Ah40; Ah42; Alzheimer’s disease; Amyloidosis; Brain; Hyperhomocysteinemia Introduction An emerging body of literature supports the concept that a high serum homocysteine level may be a risk factor for Alzheimer’s disease (AD) (Clarke et al., 1998; Seshadri et al., 2002).”
BackgroundChiuve, S. E., Giovannucci, E. L., Hankinson, S. E., Zeisel, S. H., Dougherty, L., Willett, W. C., & Rimm, E. B. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.4.1073 · Cited by 127
“High total homocysteine (tHcy) concentrations have been associated with a greater risk of many chronic diseases, such as cardiovascular disease (1), cancer (2), cognitive decline (3), and bone fractures (4).”
BackgroundOne-Carbon Metabolism and Alzheimers Disease: Focus on Epigenetics
Coppede, F. (2010) · Current Genomics · doi:10.2174/138920210791233090 · Cited by 117
“For istance, folate deficiency fosters a decline in SAM, decreasing DNA methylation during aging and AD [14,120].”
BackgroundBiochemical indicators of vitamin B 12 and folate insufficiency and cognitive decline
Tangney, C. C., Tang, Y., Evans, D. A., & Morris, M. C. (2009) · Neurology · doi:10.1212/01.wnl.0000341272.48617.b0 · Cited by 117
Davey, A., Elias, M. F., Robbins, M. A., Seliger, S. L., & Dore, G. A. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs470 · Cited by 133
Cao, X., Lin, W., & Yu, Q. (2011) · The Journal of Organic Chemistry · doi:10.1021/jo201199k · Cited by 117
Wiltfang, J., Lewczuk, P., Riederer, P., Grünblatt, E., Hock, C., Scheltens, P., Hampel, H., Vanderstichele, H., Iqbal, K., Galasko, D., et al. (2005) · The World Journal of Biological Psychiatry · doi:10.1080/15622970510029786 · Cited by 117
“A value greater than 14 mmol/l was associated with a twofold increased risk of developing AD (Seshadri et al. 2002).”
BackgroundPlasma vitamin B12 status and cerebral white-matter lesions
de Lau, L. M. L., Smith, A. D., Refsum, H., Johnston, C., & Breteler, M. M. B. (2009) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.149286 · Cited by 117
Copper toxicity in Alzheimer's disease: Cognitive loss from ingestion of inorganic copper
Brewer, G. J. (2012) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2012.04.019 · Cited by 116
Turn-on Luminescent Probe for Cysteine/Homocysteine Based on a Ruthenium(II) Complex
Zhang, R., Yu, X., Ye, Z., Wang, G., Zhang, W., & Yuan, J. (2010) · Inorganic Chemistry · doi:10.1021/ic100810z · Cited by 119
Epigenetics: A novel therapeutic approach for the treatment of Alzheimer's disease
Adwan, L., & Zawia, N. H. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.03.010 · Cited by 115
“…and the lack of a placebo-treated control group suggest that further trials are needed to properly evaluate betaine's efficacy in AD (Knopman & Patterson, 2001), especially that elevated homocysteine has been associated with dementia and AD and betaine lowers homocysteine (Seshadri et al., 2002).”
Zhang, J., Ji, X., Zhou, J., Chen, Z., Dong, X., & Zhao, W. (2017) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2017.10.133 · Cited by 116
Coumarinocoumarin-Based Two-Photon Fluorescent Cysteine Biosensor for Targeting Lysosome
Chen, C., Zhou, L., Liu, W., & Liu, W. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b00434 · Cited by 114
HIRSCHOWITZ, B. I., WORTHINGTON, J., & MOHNEN, J. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03658.x · Cited by 117
Homocysteine and the Brain in Midadult Life: Evidence for an Increased Risk of Leukoaraiosis in Men
Sachdev, P., Parslow, R., Salonikas, C., Lux, O., Wen, W., Kumar, R., Naidoo, D., Christensen, H., & Jorm, A. (2004) · Archives of Neurology · doi:10.1001/archneur.61.9.1369 · Cited by 114
“Homocysteine has, in addition, been suggested as a risk factor for brain atrophy in healthy subjects(8) and alcoholics(9) and has been proposed to increase the risk of Alzheimer disease.(10,11) Cross-sectional studies have found an inverse relationship between elevated HCY levels and cognitive function in healthy popu…”
BackgroundA BODIPY based fluorescent chemosensor for Cu(II) ions and homocysteine/cysteine
Li, Q., Guo, Y., & Shao, S. (2012) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2012.05.086 · Cited by 118
Wang, Z., Han, D., Jia, W., Zhou, Q., & Deng, W. (2012) · Analytical Chemistry · doi:10.1021/ac300512b · Cited by 114
Ma, Y., Liu, S., Yang, H., Wu, Y., Yang, C., Liu, X., Zhao, Q., Wu, H., Liang, J., Li, F., et al. (2011) · Journal of Materials Chemistry · doi:10.1039/c1jm13513a · Cited by 115
Chang, H., Chang, Y.-F., Fan, N., & Ho, J. A. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am504546f · Cited by 115
Sex-related differences in oxidative stress and neurodegeneration
Tenkorang, M. A., Snyder, B., & Cunningham, R. L. (2018) · Steroids · doi:10.1016/j.steroids.2017.12.010 · Cited by 113
“contribute to dementia and AD progression [133-141].”
Souto, J. C., Blanco‐Vaca, F., Soria, J. M., Buil, A., Almasy, L. A., Ordóñez‐Llanos, J., Martín-Campos, J. M., Lathrop, M. G., Stone, W. H., Blangero, J., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/430409 · Cited by 124
“Furthermore, recent data from the Framingham Study indicate that plasma homocysteine (Hcy) level is also a dose-related risk marker for the development of dementia and Alzheimer disease (Seshadri et al. 2002).”
BackgroundFolate in Wheat Genotypes in the HEALTHGRAIN Diversity Screen
Piironen, V., Edelmann, M., Kariluoto, S., & Bedő, Z. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf801066j · Cited by 113
Molecular Targeting of Proteins by L-Homocysteine: Mechanistic Implications for Vascular Disease
Glushchenko, A. V., & Jacobsen, D. W. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1809 · Cited by 124
“Elevated homocysteine is also associated with Alzheimer’s disease and other disorders of cognitive function (18, 114).”
Bioavailability of food folates is 80% of that of folic acid
Winkels, R. M., Brouwer, I. A., Siebelink, E., Katan, M., & Verhoef, P. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.2.465 · Cited by 113
B vitamins and the aging brain: Nutrition Reviews©, Vol. 68, No. s2
Selhub, J., Troen, A. M., & Rosenberg, I. H. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00346.x · Cited by 127
Self-citationYang, Y., Shim, S., & Tae, J. (2010) · Chemical Communications · doi:10.1039/c0cc02381g · Cited by 112
Bai, Y., Xu, J., & Chen, H. (2009) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2009.03.008 · Cited by 112
Helicobacter pylori and Alzheimer's disease: a possible link
Malaguarnera, M., Bella, R., Alagona, G., Ferri, R., Carnemolla, A., & Pennisi, G. (2004) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2004.05.008 · Cited by 112
“An increased plasma Hcy level is an independent risk factor for vascular disease [19] as well as for dementia and AD [20].”
BackgroundA Highly Selective FRET‐Based Fluorescent Probe for Detection of Cysteine and Homocysteine
Shiu, H., Chong, H.-C., Leung, Y., Wong, M., & Che, C. (2010) · Chemistry - A European Journal · doi:10.1002/chem.200903121 · Cited by 111
Morris, M. S., Selhub, J., & Jacques, P. F. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.04076.x · Cited by 112
“Furthermore, another study found an association between plasma homocysteine concentrations measured at Examination 20 of the original Framingham cohort and MMSE score decline, but only after 4 years or more of follow-up.(39) A population’s nutritional status should also be considered when interpreting results.”
BackgroundSelf-citationHyperhomocysteinemia as a risk factor for the neuronal system disorders.
Petráš, M., Tatarková, Z., Kovalská, M., Mokrá, D., Dobrota, D., Lehotský, J., & Drgova, A. (2014) · PubMed · Cited by 112
Grimm, M. O. W., Michaelson, D. M., & Hartmann, T. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r076331 · Cited by 109
Hyperhomocysteinemia: Clinical Insights
Mutairi, F. A. (2020) · Journal of Central Nervous System Disease · doi:10.1177/1179573520962230 · Cited by 132
Selley, M. L. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.08.003 · Cited by 121
Gupta, S., Kühnisch, J., Mustafa, A., Lhoták, Š., Schlachterman, A., Slifker, M. J., Klein–Szanto, A. J., High, K. A., Austin, R. C., & Kruger, W. D. (2008) · The FASEB Journal · doi:10.1096/fj.08-120584 · Cited by 111
Will caloric restriction and folate protect against AD and PD?
Mattson, M. P. (2003) · Neurology · doi:10.1212/01.wnl.0000042785.02850.11 · Cited by 111
A colorimetric chemosensor for the sequential detection of copper(II) and cysteine
Lee, S. A., Lee, J. J., Shin, J. W., Min, K. S., & Kim, C. (2015) · Dyes and Pigments · doi:10.1016/j.dyepig.2015.01.020 · Cited by 110
Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients
Lamberti, P., Zoccolella, S., Iliceto, G., Armenise, E., Fraddosio, A., Mari, M. D., & Livrea, P. (2004) · Movement Disorders · doi:10.1002/mds.20261 · Cited by 110
Kronenberg, G., Harms, C., Sobol, R. W., Cardozo‐Pelaez, F., Linhart, H., Winter, B., Balkaya, M., Gertz, K. R., Gay, S. B., Cox, D., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0940-08.2008 · Cited by 118
“There is also increasing evidence for a beneficial effect of folate in protecting against Alzheimer’s disease and cognitive decline with age (Seshadri et al., 2002; Nurk et al., 2005; Durga et al., 2007; Luchsinger et al., 2007).”
BackgroundHomocysteine levels in newly admitted schizophrenic patients
Applebaum, J., Shimon, H., Sela, B., Belmaker, R. H., & Levine, J. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.01.003 · Cited by 110
VITAL Trial Collaborative Group (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01154.x · Cited by 110
Wang, X.-L., Zeng, J., Yang, Y., Xiong, Y., Zhang, Z.-H., Qiu, M., Yan, X., Sun, X.-Y., Tuo, Q.-Z., Liu, R., et al. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140198 · Cited by 107
“pylori infection [35, 36], which is related with a high risk of AD [37, 38].”
BackgroundAssay of Biothiols by Regulating the Growth of Silver Nanoparticles with C-Dots as Reducing Agent
Shen, L., Chen, Q., Sun, Z.-Y., Chen, X., & Wang, J. (2014) · Analytical Chemistry · doi:10.1021/ac500601k · Cited by 114
Fatty acids, lipid metabolism and Alzheimer pathology
Hooijmans, C. R., & Kiliaan, A. J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.081 · Cited by 142
“, 2007) (13)(Seshadri et al., 2002) (14)(Casserly and Topol, 2004) (15)(Hofman et al.”
Environmental and dietary risk factors in Alzheimer’s disease
Dosunmu, R., Wu, J., Basha, M. R., & Zawia, N. H. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.7.887 · Cited by 109
Rhodamine-based fluorogenic probe for imaging biological thiol
Shibata, A., Furukawa, K., Abe, H., Tsuneda, S., & Ito, Y. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.03.014 · Cited by 109
Parkhitko, A. A., Binari, R., Zhang, N., Asara, J. M., Demontis, F., & Perrimon, N. (2016) · Genes & Development · doi:10.1101/gad.282277.116 · Cited by 109
“Moreover, elevated homocysteine levels have been reported as a risk factor for dementia and Alzheimer ’ s disease (Seshadri et al. 2002).”
Zhu, X., Zhao, T., Nie, Z., Miao, Z., Liu, Y., & Yao, S. (2016) · Nanoscale · doi:10.1039/c5nr07826a · Cited by 108
Kidney Function and Cognitive Performance and Decline in Older Men
Slinin, Y., Paudel, M. L., Ishani, A., Taylor, B. C., Yaffe, K. S., Murray, A. M., Fink, H. A., ORWOLL, E. S., Cummings, S. R., Barrett-Connor, E. L., et al. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01936.x · Cited by 117
Beydoun, M. A., Gamaldo, A. A., Canas, J. A., Beydoun, H. A., Shah, M. T., McNeely, J. M., & Zonderman, A. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103490 · Cited by 119
“[1,2,3,4,5,6,7,8,9,10,11,12,13,14]).”
Işık, M., Guliyev, R., Kölemen, S., Altay, Y., Şentürk, B., Tekinay, T., & Akkaya, E. U. (2014) · Organic Letters · doi:10.1021/ol501272z · Cited by 107
Progressive Resistance Exercise and Parkinson's Disease: A Review of Potential Mechanisms
David, F. J., Rafferty, M. R., Robichaud, J. A., Prodoehl, J., Kohrt, W. M., Vaillancourt, D. E., & Corcos, D. M. (2011) · Parkinson s Disease · doi:10.1155/2012/124527 · Cited by 131
“These include the reduction in serum levels of homocysteine [96] and the increase in serum levels of insulin-like growth factor I [97], following PRE, which are both known to be associated with cognitive function [98, 99].”
BackgroundHomocysteine levels and decline in physical function: MacArthur studies of successful aging
Kado, D. M., Bucur, A., Selhub, J., Rowe, J. W., & Seeman, T. E. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01269-x · Cited by 115
“7 Not applicable History of cardiovascular disease 58 (12) 96 (14) Incident cardiovascular disease 31 (6) 46 (7)”
BackgroundSelf-citationDietary Influences on Cognitive Function with Aging: From High‐Fat Diets to Healthful Eating
PARROTT, M. D., & GREENWOOD, C. E. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1396.028 · Cited by 107
Beard, R. S., & Bearden, S. E. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00598.2010 · Cited by 106
Risk‐reducing effect of education in Alzheimer's disease
Sando, S. B., Melquist, S., Cannon, A., Hutton, M., Sletvold, O., Saltvedt, I., White, L. R., Lydersen, S., & Aasly, J. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2043 · Cited by 106
“DOI: 10.1002/gps Luchsinger and Mayeux, 2007; Seshadri et al., 2002).”
InfluentialGuan, Y., Niu, L., Chen, Y., Wu, L., Tung, C., & Yang, Q. (2014) · RSC Advances · doi:10.1039/c3ra47116k · Cited by 109
Genetic diversity of folate profiles in seeds of common bean, lentil, chickpea and pea
Jha, A. B., Ashokkumar, K., Diapari, M., Ambrose, S. J., Zhang, H., Tar’an, B., Bett, K. E., Vandenberg, A., Warkentin, T. D., & Purves, R. W. (2015) · Journal of Food Composition and Analysis · doi:10.1016/j.jfca.2015.03.006 · Cited by 117
“It is also associated with numerous neurodegenerative disorders, including Alzheimer’s disease (Seshadri et al., 2002), and various cancers (Choi and Friso, 2005).”
BackgroundPolypoidal Choroidal Vasculopathy in Asians
Wong, C. W., Wong, T. Y., & Cheung, C. M. G. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4050782 · Cited by 110
“heart disease [63], dementia [64] and Alzheimer’s disease [64].”
BackgroundXiang, H., Tham, H. P., Nguyen, M. D., Phua, S. Z. F., Lim, W. Q., Liu, J., & Zhao, Y. (2017) · Chemical Communications · doi:10.1039/c7cc01814b · Cited by 108
Epigenetics in neurodegeneration: A new layer of complexity
Marques, S., Oliveira, C. R., Pereira, C., & Outeiro, T. F. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.08.008 · Cited by 116
“Several epidemiological papers showed that hyperhomocysteinemia may be a risk factor for AD (Seshadri et al., 2002, Luchsinger and Mayeux, 2004, Ravaglia et al., 2005).”
BackgroundWei, H.-J., Xu, J.-H., Li, M.-H., Tang, J.-P., Zou, W., Zhang, P., Wang, L., Wang, C.-Y., & Tang, X.-Q. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.197 · Cited by 106
Metadata
- Authors
- Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A.
- Affiliations
- Boston University (US)
- Tufts University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-02-14
- Volume
- 346
- Issue
- 7
- Pages
- 476-483
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2052588755
- Cited by
- 3,237
- References
- 55
- Citations by year
- 2026: 49 · 2025: 61 · 2024: 82 · 2023: 79 · 2022: 90 · 2021: 102 · 2020: 91 · 2019: 133 · 2018: 132 · 2017: 138 · 2016: 138 · 2015: 149 · 2014: 174 · 2013: 154 · 2012: 155
- FWCI
- 111.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hc038038-022)
- National Institute on Aging (5R01 AG 08122-11, 5R01-AG16495-02, R01AG016495, R01AG008122)
- National Heart, Lung, and Blood Institute (N01-HC-38038)
- National Institute of Neurological Disorders and Stroke (5R01 NS 17950-19, R01NS017950)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- plasma homocysteine, dementia, Alzheimer's disease, risk factors, newly diagnosed dementia, folic acid, vitamin B12, vitamin B6, apolipoprotein E, Framingham Heart Study, cognitive decline
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Apolipoproteins E, Dementia, Female, Homocysteine, Humans, Male, Risk Factors, Cohort Studies, Confounding Factors, Epidemiologic, Multivariate Analysis, Proportional Hazards Models, Hyperhomocysteinemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.